CNC
Centene Corporation
CNC's fundamentals are strong, but it looks expensive: trading at 23x earnings, above its usual 19x. Analysts expect strong earnings growth, though they disagree widely on how much.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
CNC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
CNC's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
CNC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $34.05 | -52% |
| Forward | 13x | $70.27 | — |
| Fair | 19x | $57.25 | -19% |
| Current | 23x | $70.27 | — |
| Expensive | 33x | $100 | +43% |
Historical ranges are pointers, not guarantees.
CNC's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
CNC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect CNC's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.24 | +74% |
| Q3 2026 | $3.01 | +$13.76 |
| Q2 2026 | -$10.35 | -352% |
| Q1 2026 | -$13.05 | -292% |
| Q4 2025 | -$13.53 | -314% |
| Q3 2025 | -$10.75 | -285% |
| Q2 2025 | $4.11 | -23% |
| Q1 2025 | $6.78 | +34% |
| Q4 2024 | $6.31 | +27% |
CNC has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
CNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.6B | +1.9% |
| Q2 2026 | $53.6B | +9.9% |
| Q1 2026 | $49.9B | +7.1% |
| Q4 2025 | $49.7B | +22% |
| Q3 2025 | $49.7B | +18% |
| Q2 2025 | $48.7B | +22% |
| Q1 2025 | $46.6B | +15% |
| Q4 2024 | $40.8B | +3.4% |
CNC's revenue has grown year over year every quarter since late 2020: $50.6B last quarter, up 1.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | +13 points |
| Q2 2026 | 2.2% | +3.2 points |
| Q1 2026 | 3.7% | +0.4 points |
| Q4 2025 | -3.5% | -3.9 points |
| Q3 2025 | -14% | -16 points |
| Q2 2025 | -0.9% | -4 points |
| Q1 2025 | 3.3% | +0.5 points |
| Q4 2024 | 0.4% | +0.9 points |
CNC has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over CNC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
CNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.9B | -437% |
| Q2 2026 | $3.4B | +117% |
| Q1 2026 | $4.2B | +203% |
| Q4 2025 | $224M | +$965M |
| Q3 2025 | $1.1B | +$2.3B |
| Q2 2025 | $1.6B | -21% |
| Q1 2025 | $1.4B | +$2B |
| Q4 2024 | -$741M | -$735M |
CNC usually generates cash, though not every quarter: the latest was −$3.9B, but it generated $3.9B over the past year.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over CNC on cash flow, with more consistent year-over-year improvement.
CNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -3.5M shares |
| 1 year | +0.6% | +3M shares |
| 3 years | -8.7% | -47.1M shares |
| 5 years | -16% | -96.6M shares |
| Available history | -10% | -57.9M shares |
CNC has 494M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $24M |
| Q2 2026 | $4M |
| Q1 2026 | $29M |
| Q4 2025 | $2M |
| Q3 2025 | — |
| Q2 2025 | $432M |
| Q1 2025 | $41M |
| Q4 2024 | $943M |
CNC spent $59M buying back its own shares over the past year, down 96% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over CNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
CNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 1.0x | Healthy |
| Q3 2024 | 0.8x | Very low |
| Q2 2024 | 0.0x | Very low |
| Q1 2024 | 0.1x | Very low |
| Q4 2023 | 0.2x | Very low |
CNC has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
CNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.0 | Neutral |
| Stochastic | 62.6 | Neutral |
CNC's weekly RSI is 64 (neutral) and its Stochastic is 63 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
CNC PE vs Healthcare Sector
| Metric | CNC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 9.7% below |
| PE % | 64 | 29 | 35 pts above |
CNC is trading at 23x earnings, in line with the Healthcare sector's median of 26x.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
CNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $67.3 | 4.5% above |
| 20 week MA | $66.3 | 5.9% above |
| 50 week MA | $54.3 | 29% above |
| 100 week MA | $51.0 | 38% above |
| 200 week MA | $60.6 | 16% above |
CNC has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $63.7 | $58.0 | -8.8% |
| 2021 | $58.0 | $84.7 | +46% |
| 2022 | $84.7 | $81.6 | -3.6% |
| 2023 | $81.6 | $74.2 | -9.1% |
| 2024 | $74.2 | $60.6 | -18% |
| 2025 | $60.6 | $40.5 | -33% |
| 2026 YTD | $40.5 | $70.3 | +73% |
CNC has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.